Device type · JPA
System, Multipurpose For In Vitro Coagulation Studies
Last checked: Nov 19, 2026Source: openFDAMethods & limitations
Product code
JPA
Hematology
Device class
Class II
FDA decisions since 2015
27
510(k), De Novo and PMA
Adverse event reports
12
Received Nov 1, 2025 to Nov 19, 2026
How FDA classifies it
- Device type
- System, Multipurpose For In Vitro Coagulation Studies
- Product code
- JPA
- Device class
- Class II
- Review panel
- Hematology
- Regulation
- 21 CFR 864.5425
- Specialty
- Laboratory Medicine & Pathology
- FDA record
- Classification database entry for JPA
Latest FDA decisions
The 8 newest of 27 since 2015.
K260909 · Decided Oct 27, 2026 · 222 days after receipt
Device type: System, Multipurpose For In Vitro Coagulation Studies (JPA) · Laboratory Medicine & Pathology
- STA Satellite Max®510(k)
K253658 · Decided Apr 27, 2026 · 158 days after receipt
Device type: System, Multipurpose For In Vitro Coagulation Studies (JPA) · Laboratory Medicine & Pathology
K250965 · Decided Jun 2, 2025 · 63 days after receipt
Device type: System, Multipurpose For In Vitro Coagulation Studies (JPA) · Laboratory Medicine & Pathology
24 more FDA decisions with a free account
Reports received
12
Received Nov 1, 2025 to Nov 19, 2026
Malfunction reports
7
58% of reports
Injury reports
3
25% of reports
Death reports
2
17% of reports
Adverse event reports received per month
By the date FDA received each report, stacked by event type. The newest month is incomplete.
- Malfunction
- Injury
- Death
- Other
View as table
| Month | Malfunction | Injury | Death | Other |
|---|---|---|---|---|
| Dec 23 | 0 | 0 | 0 | 0 |
| Jan 24 | 0 | 0 | 0 | 0 |
| Feb 24 | 0 | 2 | 0 | 0 |
| Mar 24 | 0 | 1 | 0 | 0 |
| Apr 24 | 1 | 0 | 0 | 0 |
| May 24 | 0 | 0 | 0 | 0 |
| Jun 24 | 0 | 0 | 0 | 0 |
| Jul 24 | 0 | 0 | 1 | 0 |
| Aug 24 | 2 | 0 | 0 | 0 |
| Sep 24 | 0 | 0 | 0 | 0 |
| Oct 24 | 0 | 0 | 0 | 0 |
| Nov 24 | 0 | 0 | 0 | 0 |
| Dec 24 | 0 | 1 | 0 | 0 |
| Jan 25 | 0 | 0 | 0 | 0 |
| Feb 25 | 0 | 0 | 0 | 0 |
| Mar 25 | 0 | 0 | 0 | 0 |
| Apr 25 | 1 | 0 | 0 | 0 |
| May 25 | 0 | 0 | 0 | 0 |
| Jun 25 | 0 | 3 | 0 | 0 |
| Jul 25 | 0 | 0 | 1 | 0 |
| Aug 25 | 0 | 0 | 0 | 0 |
| Sep 25 | 0 | 0 | 0 | 0 |
| Oct 25 | 3 | 2 | 0 | 0 |
| Nov 25 | 1 | 0 | 0 | 0 |
| Dec 25 | 0 | 0 | 0 | 0 |
| Jan 26 | 0 | 0 | 0 | 0 |
| Feb 26 | 0 | 0 | 0 | 0 |
| Mar 26 | 0 | 0 | 1 | 0 |
| Apr 26 | 1 | 0 | 0 | 0 |
| May 26 | 1 | 0 | 0 | 0 |
| Jun 26 | 1 | 0 | 0 | 0 |
| Jul 26 | 3 | 0 | 0 | 0 |
| Aug 26 | 0 | 0 | 0 | 0 |
| Sep 26 | 0 | 0 | 0 | 0 |
| Oct 26 | 0 | 3 | 1 | 0 |
| Nov 26 | 0 | 0 | 0 | 0 |
Manufacturers named most often
Last 12 months. Bigger sellers get more reports. This is not a ranking of safety.
3 more in this ranking with a free account
Device problems as coded
Last 12 months. FDA's terms. A report can carry several.
- Insufficient Device Problem Information3
- High Test Results2
- Low Test Results2
7 more in this ranking with a free account
Patient problems as coded
Last 12 months. FDA's terms. A report can carry several.
- No Clinical Signs, Symptoms or Conditions7
- Thrombosis/Thrombus2
- Cardiogenic Shock1
3 more in this ranking with a free account
Recent recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
- Hemochron Jr., Whole Blood Microcoagulation System, Activated Partial Thromboplastin Time (APTT) Test Cuvette, REF: J103Open, Classified
Z-0317-2027 · Started Sep 14, 2026 · Posted by FDA Oct 30, 2026
Reason given: Microcoagulation test used to evaluate low dose heparin anticoagulation has a mispositioned or absent clot activating reagent, which may result in out-of-range high error code, or erroneously high results, which may lead retest, or overestimation of patient's anticoagulation, leading to inadequate anticoagulant...
Cause as FDA categorized it: Process control
Z-2473-2025 · Started Jul 21, 2025 · Posted by FDA Aug 28, 2025
Reason given: Potential for contamination of STA-LIQUID ANTI-Xa by Stago Fibrinogen reagents in UFH and LMWH applications.
Cause as FDA categorized it: Mixed-up of materials/components
- STA R Max fully automatic clinical instrument designed to perform tests on human plasmas, Reference Numbers 59013 and 59026Open, Classified
Z-1575-2023 · Started Mar 22, 2023 · Posted by FDA May 10, 2023
Reason given: An internal investigation identified a bug in this firmware version, resulting in the following:Intermittent shortened coagulation times and an increased frequency of occurrence of a technical error reported by the analyzer (error 13).
Cause as FDA categorized it: Device Design
41 more recall records with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.